Key Pediatric Clinical Practice Guidelines in 2017

John Anello; Brian Feinberg; John Heinegg; Yonah Korngold; Richard Lindsey; Cristina Wojdylo; Olivia Wong, DO


January 10, 2018

In This Article

Seasonal Allergic Rhinitis

Joint Task Force on Practice Parameters; American Academy of Allergy, Asthma, and Immunology; and American College of Allergy, Asthma, and Immunology

For patients aged 12 years and older, nasal symptoms of SAR should be treated at least initially with an INCS (intranasal corticosteroid) alone rather than the INCS–oral antihistamine combination.

For initial treatment of moderate to severe SAR in patients 15 years and older, the clinician should recommend an INCS over an LTRA (leukotriene receptor antagonist).

The clinician may recommend combination therapy with an INCS and an INAH over either monotherapy, albeit with increased cost and some increased risk for side effects (intranasal antihistamine).



Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: